Alcohol Health Services Research (R01 Clinical Trial Optional)
ID: 349812Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Award Range

$0 - $500K

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/349812

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-23-251.html
Timeline
    Description

    The National Institutes of Health (NIH), through the National Institute on Alcohol Abuse and Alcoholism (NIAAA), is inviting applications for the Alcohol Health Services Research (R01 Clinical Trial Optional) grant. This funding opportunity aims to address the treatment gap for individuals with Alcohol Use Disorder (AUD) by focusing on five key areas: increasing treatment accessibility, enhancing the appeal of treatments, analyzing cost structures and insurance systems, researching the dissemination of evidence-based treatment approaches, and minimizing health disparities among affected populations. The initiative is crucial for advancing research that improves outcomes for individuals struggling with AUD, with grants available for a project period of up to five years and a direct cost limit of $500,000. Interested applicants can find more information and submit proposals by the closing date of September 7, 2026, and may contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    PAR-23-251-Full-Announcement.html
    PAR-23-251.html
    The National Institutes of Health (NIH), through the National Institute on Alcohol Abuse and Alcoholism (NIAAA), is soliciting applications for the Alcohol Health Services Research (R01 Clinical Trial Optional) funding opportunity. This initiative aims to address the treatment gap for individuals with Alcohol Use Disorder (AUD) by focusing on five key areas: (1) increasing treatment accessibility, (2) improving the appeal of treatments, (3) analyzing cost structures and insurance systems, (4) researching the dissemination of evidence-based treatment approaches, and (5) minimizing health disparities among affected populations. Applications can include a variety of study designs, targeting societal, organizational, and individual barriers to treatment. The project period for grants may be up to five years, with a direct cost limit of $500,000 without prior approval. Eligible applicants encompass a wide range of institutions, including higher education, nonprofits, and government entities. With key deadlines set for proposal submissions, NIH encourages early applications to facilitate the submission process. Together, these efforts reflect a commitment to advancing research aimed at improving outcomes for individuals struggling with AUD.
    Similar Opportunities
    Alcohol Health Services Research (R34 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Alcohol Abuse and Alcoholism (NIAAA), has announced a funding opportunity titled "Alcohol Health Services Research (R34 Clinical Trial Optional)" (PAR-23-252). This initiative aims to address the treatment gap for individuals with Alcohol Use Disorder (AUD) by focusing on improving access to treatment, reducing stigma, examining cost structures, and implementing evidence-based approaches, particularly for health disparity populations. The total project budget is capped at $450,000 over a three-year period, and eligible applicants include higher education institutions, nonprofits, and government agencies, with a specific emphasis on those serving underrepresented communities. Interested parties should submit their applications electronically by October 16, 2023, with funding available until September 8, 2026. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Alcohol Treatment, Pharmacotherapy, and Recovery Research (R01 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Alcohol Treatment, Pharmacotherapy, and Recovery Research (R01 Clinical Trial Required)" aimed at advancing research in the treatment and recovery from alcohol use disorder (AUD). This grant supports clinical trials focusing on various aspects of AUD, including medication development, behavioral therapies, and innovative treatment technologies, particularly for populations facing health disparities. The funding is crucial for enhancing the understanding and efficacy of AUD treatments, ultimately contributing to improved public health outcomes. Eligible applicants can receive up to $500,000 in direct costs over a maximum project period of five years, with key submission deadlines on October 5, 2023, and February 5, 2024. For more information, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage at https://grants.nih.gov/grants/guide/pa-files/PAR-23-250.html.
    Alcohol Treatment, Pharmacotherapy, and Recovery Research (R34 Clinical Trial required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting proposals for the R34 Clinical Trial mechanism focused on Alcohol Treatment, Pharmacotherapy, and Recovery Research. This initiative aims to enhance understanding and treatment strategies for Alcohol Use Disorder (AUD) through clinical trials, with a particular emphasis on increasing access to treatment, improving treatment appeal, examining cost structures, and addressing health disparities among affected populations. The program is open to a diverse range of applicants, including educational institutions, nonprofits, and government agencies, with funding limits set at $450,000 over a maximum three-year project period. Interested parties must submit their applications by October 16, 2023, and can direct inquiries to grantsinfo@nih.gov for further information.
    Specialized Alcohol Research Centers (P50 Clinical trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for the establishment of Specialized Alcohol Research Centers (P50), aimed at advancing interdisciplinary research on Alcohol Use Disorder (AUD) and related issues. This initiative seeks to foster collaborative research that examines the etiology, treatment, and prevention of AUD, particularly focusing on health disparities among various racial and ethnic populations. The total funding commitment for this opportunity is up to $7 million, with applications due by November 15, 2024, and a requirement for a Plan for Enhancing Diverse Perspectives (PEDP) to be included in submissions. Interested applicants can find more information and submit their proposals electronically through Grants.gov, with inquiries directed to grantsinfo@nih.gov.
    Investigational New Drug (IND)-enabling and Early-Stage Development of Medications to Treat Alcohol Use disorder and Alcohol-Associated Organ Damage (U43/U44 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a Funding Opportunity Announcement (FOA) aimed at supporting the development of medications for Alcohol Use Disorder (AUD) and Alcohol-Associated Organ Damage (AAOD) through Small Business Innovation Research (SBIR) applications. Eligible applicants, specifically U.S.-based small businesses, are required to propose therapeutic agents that have a solid foundation of background data, ready for transition to preclinical and clinical development, with a focus on advancing these candidates towards FDA approval. This initiative is critical given the limited FDA-approved treatments available for AUD and AAOD, and it emphasizes the importance of rigorous scientific and regulatory standards in drug development. Funding amounts include up to $1 million for Phase I and $1.5 million for Phase II, with project durations of up to two years and three years, respectively. Interested parties can find more information and contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov, with the application deadline set for December 4, 2024.
    Alcohol Research-Related Resource Award (R24 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced the Alcohol Research-Related Resource Award (R24 Clinical Trial Not Allowed), aimed at supporting investigator-initiated resources that enhance biomedical, behavioral, and social sciences research related to alcohol. This grant mechanism focuses on providing essential data, materials, and services to the broader alcohol research community, rather than supporting hypothesis-driven research, which should be submitted through other mechanisms. The NIH seeks to create high-quality resources that do not duplicate existing offerings, emphasizing the importance of diversity in research participation and encouraging applications from organizations serving underrepresented groups. Applications are due by January 25, 2024, and the project periods can last up to five years, with no cost-sharing or matching requirements. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Alcohol and Other Substance Use Research Education Programs for Health Professionals (R25 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Alcohol Abuse and Alcoholism (NIAAA) and the National Institute on Drug Abuse (NIDA), is offering a funding opportunity titled "Alcohol and Other Substance Use Research Education Programs for Health Professionals." This initiative aims to support educational activities that enhance healthcare professionals' understanding of biomedical, behavioral, and clinical research related to alcohol and substance use disorders, with a focus on outreach to disseminate research findings effectively. The program encourages diverse participation and aims to recruit healthcare providers for education on current and emerging knowledge in addiction science, with funding available for projects not exceeding $250,000 per year for up to four years. Interested applicants should submit their proposals electronically through Grants.gov by May 25, 2026, and can contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Behavioral and Integrative Treatment Development Program (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled the Behavioral and Integrative Treatment Development Program (R01 Clinical Trial Optional) aimed at promoting research for innovative behavioral and integrative treatments for drug and alcohol use disorders. This initiative encourages the development and testing of interventions across various stages, from initial generation and refinement to efficacy testing in controlled and real-world settings, focusing on enhancing treatment efficacy and accessibility, particularly in community environments. Applications are welcomed from a diverse range of organizations, including higher education institutions and for-profit entities, with no budget limit specified, and must be submitted by March 21, 2025. For further inquiries, interested parties can contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov, and additional details can be found at the provided link: http://grants.nih.gov/grants/guide/pa-files/PAR-22-182.html.
    Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 - Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 - Clinical Trial Optional)." This initiative aims to support pilot and preliminary research that prepares for larger-scale trials focused on improving access to and the effectiveness of treatment services for substance use disorders. The funding is intended to facilitate the testing of various intervention approaches and methodologies, ultimately contributing to the development of effective treatment strategies that address health disparities among vulnerable populations. Applicants may receive up to $450,000 over a three-year period, with proposals due by 5:00 PM local time on January 7, 2025. For further information, interested parties can contact the NIH OER Webmaster at grantsinfo@nih.gov or visit the official announcement at http://grants.nih.gov/grants/guide/pa-files/PA-21-180.html.
    Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the "Population Approaches to Reducing Alcohol-related Cancer Risk" funding opportunity, designated as R01 Clinical Trial Optional. This initiative aims to support interdisciplinary research focused on increasing awareness of the link between alcohol consumption and cancer risk, altering social norms regarding alcohol use, evaluating alcohol policy approaches, and developing population-level interventions to mitigate alcohol-related cancer risks. The funding is particularly relevant for addressing alcohol use disorders and disparities faced by underrepresented minority populations, with applications due between January 5, 2024, and October 5, 2026, and project periods extending up to five years. There is no specific budget limit for applications, which should reflect the actual needs of the proposed projects. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov, and additional details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-23-244.html.